Dysfunctional breathing (DB) is a respiratory condition characterized by irregular breathing patterns that occur either in the absence of concurrent diseases or secondary to cardiopulmonary diseases. Although the primary symptom is often dyspnea or "air hunger", DB is also associated with nonrespiratory symptoms such as dizziness and palpitations. DB has been identifi ed across all ages. Its prevalence among adults in primary care in the United Kingdom is approximately 9.5%. In addition, among individuals with asthma, a positive diagnosis of DB is found in a third of women and a fi fth of men. Although DB has been investigated for decades, it remains poorly understood because of a paucity of high-quality clinical trials and validated outcome measures specifi c to this population. Accordingly, DB is often underdiagnosed or misdiagnosed, given the similarity of its associated symptoms (dyspnea, tachycardia, and dizziness) to those of other common cardiopulmonary diseases such as COPD and asthma. The high rates of misdiagnosis of DB suggest that health care professionals do not fully understand this condition and may therefore fail to provide patients with an appropriate treatment. Given the multifarious, psychophysiological nature of DB, a holistic, multidimensional assessment would seem the most appropriate way to enhance understanding and diagnostic accuracy. The present narrative review was developed as a means of summarizing the available evidence about DB, as well as improving understanding of the condition by researchers and practitioners.
INTRODUCTION
Dysfunctional breathing (DB) is a respiratory condition that is often poorly understood among health care professionals worldwide, leading to its underdiagnosis and misdiagnosis in clinical practice. (1, 2) The reasons for its misdiagnosis include a lack of studies investigating its pathophysiology, classifi cation, and symptoms, as well as the similarity between the symptoms of DB and those of common cardiopulmonary diseases, such symptoms including dyspnea, tachycardia, dizziness, and paresthesia. (3) Misunderstandings about the causes, diagnosis, and treatment of DB appear to indicate that health care professionals do not fully understand this condition and may therefore fail to provide patients with an appropriate treatment, which could lead to impaired health-related quality of life (HRQoL). (4) What is known to date is that DB involves different forms of abnormal breathing patterns, (5) and that it affects approximately 9.5% of all adults in primary care in the United Kingdom. (5) DB has been shown to occur in individuals from 17 to 88 years of age, (2, 6, 7) being most common in women and in individuals with asthma. (5, 8) However, the prevalence of DB can be overestimated or underestimated, given the fact that there is currently no gold-standard tool for diagnosing the condition. Therefore, in this narrative review, we will discuss the defi nition of DB, as well as the evidence base for its physiological, functional, and psychological characteristics. Our intention is to improve understanding of DB, based on the available scientifi c evidence, on the part of health care professionals.
DEFINITION AND CLASSIFICATION OF DB
DB is generally characterized by abnormal breathing patterns (4, 9) that occur either in the absence of organic diseases (i.e., due to psychogenic causes such as anxiety) (10, 11) or secondary to cardiopulmonary/neurological diseases (i.e., due to organic/physiological causes such as asthma and heart failure). (5, 12) Jones et al. (6) dubbed the former classifi cation "primary DB" and the latter "secondary DB". (6) It is noteworthy that DB is secondary to organic causes when the physiological alterations are insuffi cient to explain the evident symptoms (e.g., dyspnea) or the blood gas analysis results. (13) Figure 1 shows a representation of "abnormal breathing patterns". It is important to emphasize that those abnormal patterns can appear with greater recruitment of the accessory muscles of respiration or in cases of chronic respiratory alkalosis. (4, 14, 15) In recent years, researchers have proposed some alternative classifi cations for different patterns of DB. Barker and Everard (4) reviewed the literature and suggested a new defi nition of DB: "an alteration in the normal biomechanical patterns of breathing that result in intermittent or chronic symptoms which may be respiratory and/or non-respiratory". Among the respiratory symptoms listed by the authors were dyspnea and hyperventilation, whereas their list of nonrespiratory symptoms included dizziness and tachycardia. The authors also highlighted the fact that pattern disordered breathing is the main component of any form of DB. Table 1 shows the classifi cations of DB proposed by various authors. The evident differences across studies regarding the classifi cation of DB and the terminology employed in describing it underscore the need to move from an incipient stage (of discovery) to a more developed phase (of diagnosis and treatment).
The most well-known form of DB is hyperventilation syndrome (HVS), which is defi ned as acute or chronic hyperventilation (increased minute volume) at rest or during exercise/stress. (16, 17) As a form of DB, HVS may be due to organic/physiological conditions but is mainly caused by psychological/behavioral factors (e.g., anxiety, depression, perfectionism, and feelings of inferiority). (16, 18) For many years, it was thought that HVS was always accompanied by hypocapnia, which can trigger nonrespiratory symptoms such as dizziness, palpitations, numbness, and a tingling sensation. (19) However, recent studies indicate that such symptoms could be triggered by other, as yet unknown, factors, given that respiratory alkalosis is not always present in HVS. (4, 13, 20) There is another form of DB, known as idiopathic hyperventilation (IH), in which patients have chronic asymptomatic hyperventilation and respiratory alkalosis, that cannot be attributed to an underlying disease. (18) Jack et al. (21) showed that IH is mainly caused by psychological factors, becoming a conditioned response. In a subsequent study, Jack et al. (18) hypothesized that IH is caused by increased respiratory responsiveness to carbon dioxide levels, to hypoxia, or to an increase Figure 1 . Representative fi gure showing the "normal" breathing patterns and the "abnormal" breathing patterns presented by individuals with dysfunctional breathing. Normal breathing is the standard tidal volume and respiratory rate of an individual; breath holding is when a breath is held for a period of time; a deep sigh is a deep inspiration that happens at any time during breathing; and hyperventilation is an increase in the respiratory rate, tidal volume, or both. Note: The order in which abnormal breathing patterns appear may vary. No structural or functional alterations directly associated with the symptoms of DB (e.g., phrenic nerve palsy, myopathy, and diaphragmatic eventration) Structural DB (a subdivision of thoracic and extrathoracic DB) Primarily associated with anatomical or neurological alterations (e.g., subglottic stenosis and unilateral cord palsy) in the metabolic rate, although that hypothesis has not been tested.
DIAGNOSIS OF DB

Nijmegen Questionnaire
Currently, the Nijmegen Questionnaire (NQ) is the most widely used instrument for identifying individuals with DB. (22, 23) The NQ was developed by van Dixhoorn and Duivenvoorden in 1985. (23) Although the authors did not specify whether the participants had primary or secondary HVS, they mentioned the exclusion of participants with somatic disorders, which would suggest the exclusion of those with primary DB. Nevertheless, they included no information on whether any of the participants had a history of asthma or other health conditions.
The NQ consists of 16 questions related to complaints, and the frequency of symptoms can be indicated on a scale ranging from 1 (never) to 5 (very often). It has a sensitivity and specifi city of 91% and 95%, respectively, in relation to the clinical diagnosis of HVS. The questions are primarily related to physiological factors (e.g., cardiovascular and respiratory symptoms) and psychological factors (e.g., tension). However, it is noteworthy that this instrument was developed as a symptom-based questionnaire to screen for HVS. (23) In fact, the NQ has been validated only for use in patients with HVS secondary to asthma (i.e., not for use in those with other forms of DB). (24) In addition, the NQ has yet to be translated to Portuguese or validated for use in Brazil. In a recent article, one of the creators of the NQ stated that it has been used incorrectly worldwide, (25) stating that it should be used only to identify abnormal symptoms related to HVS and not as the gold-standard test to diagnose DB per se, because it was not created for that purpose. However, given that HVS was the fi rst form of DB to be investigated and is still the most well understood form of the condition, several tools, other than the NQ, have been developed to facilitate the identifi cation of hyperventilation (as described below).
The hyperventilation provocation test to identify HVS
The hyperventilation provocation test (HVPT) was once considered to be the cornerstone of the diagnosis of HVS. (26) The HVPT requires patients to breathe as deeply and quickly as possible for a certain length of time (typically 2 or 3 min). To determine whether patients have HVS, the authors who developed the HVPT suggested that clinicians check patient reports of symptoms and experiences during the test. If a patient reports symptoms and sensations that are similar to those experienced regularly in their daily lives, the presence of HVS can be confi rmed. (27) However, a number of researchers have begun to question whether the HVPT is a valid tool to detect HVS, because it does not differentiate between symptoms caused by hypocapnia and those caused by task-related anxiety or mechanical discomfort. (28) In such instances, the HVPT is highly likely to overestimate the prevalence of HVS. (13, 28) In addition, a delay for blood CO 2 levels to return to baseline values after an HVPT was once believed to be diagnostic of HVS. (27) However, it was later shown that the length of the delay in CO 2 recovery does not differ between patients with HVS and healthy individuals. (28) Cardiopulmonary exercise testing to identify HVS Another means of facilitating the diagnosis of HVS is cardiopulmonary exercise testing. (18, 20) Such testing has been recommended when patients do not experience HVS-related symptoms at rest but health care professionals suspect that, based on patient reports, these sensations are likely to occur during movement. (18, 20) That assumption is predicated on compelling evidence indicating that, on incremental cycle ergometer tests, individuals with chronic IH show lower end-tidal CO 2 tension, higher minute volume, slower recovery, and a higher degree of dyspnea (disproportionate to the increase in minute volume), as well as supporting lower workloads, than do healthy individuals. (18, 20, 21) Although the use of cardiopulmonary exercise testing might also facilitate the exclusion of other causes of dyspnea, (29) the protocol for the identifi cation of HVS during cardiopulmonary exercise testing has yet to be standardized. Therefore, exercise tests appear to be complementary tools that can facilitate the detection of HVS in more complex situations, in which patients do not show any of the aforementioned symptoms at rest.
PHYSIOLOGICAL CHARACTERISTICS OF DB
Pulmonary function
Although pulmonary function test parameters, such as FEV 1 and FVC, are widely used to classify respiratory diseases, they do not seem to distinguish patients with DB. Data in the literature describing pulmonary function in DB are extremely divergent. (30, 31) There is compelling evidence that individuals with primary DB have normal lung function, (1, 2, 17, 30) whereas other studies have shown that FEV 1 or FVC are 10-15% below the predicted values in such individuals. (17, 31) In addition, Agache et al. (32) showed that FEV 1 declined faster over a 12-month period in patients with asthma-induced DB (secondary DB) than in those with asthma alone. Furthermore, Jones et al. (6) reported that a 26-week breathing retraining program improved FEV 1 in patients with primary DB. These fi ndings can be explained by the fact that some patients with DB hyperventilate, which causes hypocapnia, accompanied by reduced airway caliber and increased airway resistance. (33, 34) It is well established that, when trial data are reported, pulmonary function test results should be provided as raw data (in L or mL) and as percentages of the predicted values, with the use of reference equations that are specifi c to the studied population. (35) However, most authors investigating DB (either primary or secondary) have evaluated changes in lung function by analyzing only raw data and not percentage data. (1, 2, 17, (30) (31) (32) Others have presented the data as percentages of the predicted values without indicating the reference equations used in their calculation. (17, (30) (31) (32) Courtney et al. (30) used spirometry to assess pulmonary function in a mixed group of healthy individuals and individuals with mild medical conditions (including suspected DB). Following the pulmonary function tests, participants were divided in two groups, on the basis of the results of those tests: normal and abnormal. The authors found that, in comparison with the participants who showed normal lung function, those with abnormal lung function had lower blood CO 2 levels, shorter breath-holding times, and lower oxygen saturation, as well as scoring higher (i.e., worse) on the Self-Evaluation of Breathing Questionnaire. (30) These results suggest that there is a group of patients with DB and chronic hyperventilation (and therefore hypocapnia) who have abnormal lung function. Therefore, it seems that any conclusion regarding pulmonary function in DB can be considered an attempt to simplify the multifaceted phenomena seen in individuals with DB.
It is important to emphasize that researchers and health care professionals should not expect to fi nd substantially abnormal spirometry results in individuals with primary DB, because it is not considered a respiratory disorder. Despite the fact that hypocapnia has an infl uence on airway caliber (i.e., constricts the airways), (33, 34) not all patients with DB exhibit hyperventilation. Therefore, the reported degree of pulmonary function impairment varies widely across studies of DB, which justifi es attempts to investigate this parameter in greater depth.
Respiratory muscle function
A number of studies have demonstrated abnormal function of the respiratory muscles (e.g., hyperventilation), (1, 11, 36) with or without greater recruitment of the accessory muscles of respiration, in patients with primary DB. (6, 31, 37) In healthy individuals, common situations such as emotional stress cause predominantly thoracic breathing, muscle tension, and increased respiratory muscle effort. (38) When such symptoms are persistent and have no physiological cause, they are suggestive of DB. (36) The accessory muscles of respiration also provide postural control and facilitate breathing during stressful situations, exercise, or threatening situations. (39, 40) Emotional stress and anxiety cause abdominal muscle tension, which inhibits diaphragmatic movement. That can induce thoracic breathing and greater recruitment of the accessory muscles of respiration, (6, 41) resulting in dyspnea, (42, 43) increased work of breathing, (11) and respiratory muscle fatigue. (44) In various respiratory conditions (e.g., COPD and asthma), the degree to which the accessory muscles are recruited indicates the severity of the disease. (45, 46) The accessory muscle recruitment caused by psychological conditions frequently associated with DB could result in general muscle tenderness, especially in the upper chest, shoulders, and neck. (47) In addition, some patients with DB exhibit audible, forced expiration, (47) which could be indicative of inappropriate expiratory muscle activation at rest. Many authors have speculated on whether or not respiratory muscle function (RMF) is impaired in patients with DB. (48) Therefore, there seems to be insuffi cient evidence in the literature to support a positive or negative theoretical position regarding respiratory muscle dysfunction as a feature of DB.
The existing literature indicates that RMF in DB has primarily been evaluated by measuring the breathing pattern at rest as a means of identifying thoracic/ paradoxical breathing, through the use of techniques such as manual assessment of respiratory motion. (36, 37) However, measurements of breathing pattern performed at rest provide no objective information regarding the contractile properties of the respiratory muscles. The manual assessment of respiratory motion technique has been shown to have better inter-rater reliability and validity than does respiratory inductance plethysmography (49) and is considered a valuable tool in the clinical fi eld, where practitioners have limited access to laboratory equipment. However, more robust physiological measures of RMF, such as muscle strength, endurance and mechanical power, should also be considered in this population. (50) According to Agache et al., (32) the treatment for DB frequently includes strengthening the diaphragm muscle. However, in the present review, we identifi ed no studies applying respiratory muscle training in DB. In addition, there is no evidence to support the idea that RMF is impaired in patients with DB; nor is there any evidence that inspiratory muscle training has benefi cial effects in this population. It is possible that patients with primary DB develop dynamic hyperinfl ation during hyperventilation, which would impair RMF by shortening and weakening the muscles. However, that theory remains untested. Given the paucity and inconclusive nature of the data currently available, (32, 50) we highly recommended the direct assessment of RMF.
Cardiopulmonary interactions
Respiration exerts a potent infl uence on the autonomic system. (51) Slow, controlled breathing (≈ 6 breaths/ min) increases the amplitude of respiratory sinus arrhythmia (RSA), which is a time-domain index of heart rate variability (HRV). (52) In addition to being a robust index of HRV, RSA is a complex physiological phenomenon; the function of which has yet to be fully understood. The amplitude of RSA (and therefore HRV) decreases during tachypneic or erratic breathing patterns. Patients with COPD show lower HRV, (53) which could be attributed to their abnormal breathing pattern. Furthermore, low HRV has been associated with negative prognostic indicators in a number of patient populations (e.g., patients with COPD and patients on hemodialysis).
(54,55) Accordingly, given the well-established synchrony between the respiratory and J Bras Pneumol. 2019;45(1):e20170347 4/9 cardiovascular systems, (51) it is likely that, in patients with DB, cardiovascular activity is atypical (e.g., an altered pattern of arterial blood pressure and HRV). Therefore, if a patient with DB is taught to breathe in a controlled manner, at a lower respiratory rate, sympathetic activity can be attenuated, (52) a physiological mechanism that could optimize/facilitate gas exchange and mitigate the symptoms of DB.
Courtney et al. (56) detected a signifi cant relationship between a predominantly thoracic breathing pattern and HRV indices that refl ect cardiopulmonary effi ciency in patients with DB. In the past, it has been argued that hyperventilation is a major cause of cardiac symptoms, due to the cerebral and peripheral vasoconstriction occurring secondary to hypocapnia. (26) It has been suggested that the underlying mechanism is hyperventilation and the consequent hypocapnia, which suppresses sympathetic and parasympathetic activities, the greatest decrease being observed in the parasympathetic activity in the heart. (4, 57) Hyperventilation also induces a reduction in cerebral blood fl ow as a result of hypocapnia; this mechanism is likely to account for the symptoms commonly reported in patients with DB, such as dizziness and unsteadiness. (47) Although there are psychophysiological reactions associated with DB, it remains unclear whether episodes of irregular breathing pattern have an infl uence (direct or indirect) on the autonomic nervous system.
Gas exchange and ventilation
It has been suggested that patients with DB expend more energy at rest because of their irregular breathing pattern, (11) which could be explained by anxiety-related factors and increased respiratory muscle work. However, Malmberg et al. (58) showed that, when the participants were in the supine position, gas exchange variables were similar between the patients with HVS and healthy individuals. Nevertheless, when the participants were in a standing position, the patients with HVS had lower levels of expired CO 2 and higher minute ventilation (V E ), as well as higher ventilatory equivalents for oxygen (V E /oxygen uptake), carbon dioxide (V E / carbon dioxide production), oxygen (minute volume/ oxygen uptake), and CO 2 (minute volume/carbon dioxide production), than did the healthy individuals. In addition, Jack et al. (18) reported that patients with IH (i.e., hyperventilation associated with low carbon dioxide production, unrelated to other diseases and not associated with fear) exhibit sustained hyperventilation, higher dyspnea, and lower ventilatory responsiveness to hypoxia during an incremental cycle ergometer test, in comparison with healthy individuals. However, the authors found that those same patients showed variable energy expenditure levels, as well as normal responses to hypoxia and normocapnia at a higher CO 2 level (40 mmHg). Therefore, the energy expenditure and ventilation levels of patients with DB have hitherto been under-researched. Those components are of great relevance to furthering understanding of this respiratory condition and should not be overlooked during the collection, analysis, and interpretation of data.
FUNCTIONAL CHARACTERISTICS OF DB
Functional assessments
In patients with DB, functional assessments (e.g., breath-holding tests and visual evaluation of breathing patterns) are commonly used in order to complement the identifi cation of this respiratory condition. (17) However, there is little evidence of any strong correlations between these functional outcomes and the underlying physiological parameters. (17, 56) There is also insuffi cient evidence to support direct correlations between functional outcomes and the score on the NQ. (24, 31, 36) In addition, there are no validated tools specifi cally designed to assess individuals with DB. (31) In 2011, Courtney et al. (17) investigated a group of individuals who had concerns about their breathing but had not received a diagnosis of primary or secondary DB. The authors identifi ed weak to non-existent correlations among biochemical indices (e.g., lower end-tidal CO 2 tension), breath-holding time, and symptom-related questionnaire scores. In a more recent study, involving patients with primary HVS, quality of life (QoL) measurements (domains of the Medical Outcomes Study 36-item Short-Form Health Survey) were found to correlate moderately with NQ scores, peak respiratory rate, and end-tidal CO 2 tension during cardiopulmonary exercise testing. (59) As was evident in the aforementioned studies, there is as yet insuffi cient evidence of correlations between functional parameters and DB-related symptoms and there is a need for further investigation. Future studies should also aim to recruit a larger number of patients with DB in order investigate the infl uence of DB on function-related tasks, such as the breath-holding test.
Exercise capacity
Exercise capacity is a parameter commonly affected by respiratory diseases such as COPD and cystic fi brosis. (60, 61) However, there have been few studies employing exercise capacity tests and performing physiological/psychological assessments during exercise in patients with DB, and the few that have been conducted have produced controversial results. Such studies typically recruit patients with HVS or secondary DB, as described below. Some studies have also employed progressive exercise tests to confi rm the diagnosis of HVS, as identifi ed by the presence of hyperventilation during exercise and at rest, in patients with asthma. (20) Warburton and Jack (20) suggested that cardiopulmonary exercise testing is the most sensitive tool to confi rm the diagnosis of HVS, which can be established when patients hyperventilate during exercise performed during exercise activities, such as running and cycling. However, it remains unknown whether exercise performance outcomes or variables collected during exercise are somehow useful in the assessment of other forms of DB. Chenivesse et al. (59) employed maximal cardiopulmonary exercise testing on a cycle ergometer in patients with HVS and recorded a range of respiratory variables. (59) The authors found that the patients with HVS showed exercise-related impairments (e.g., aerobic capacity below 84% of the predicted value) and hyperventilated not only at rest but also (and perhaps even more) during exercise. We fi nd it interesting that most of the patients with HVS in that study showed normal changes in the breathing pattern and a normal increase in respiratory rate, as well as normal cardiovascular responses, during maximal cardiopulmonary exercise testing. However, it is noteworthy that the authors compared their results with those of other studies investigating healthy participants; in other words, there was no direct comparison between patients with HVS and healthy individuals in their study.
Howell (13) suggested that symptoms of HVS occur predominately at rest but can occur during exercise, proposing that such symptoms are not directly associated with the intensity of the exercise performed.
(13) Jack et al. (21) systematically investigated that proposition and found it to hold true. In the latter study, a group of patients were observed to hyperventilate prior to or at the onset of the exercise test, a psychological condition dubbed anticipatory anxiety. (62) In such instances, patients tend to hyperventilate when facing a challenging situation. It is noteworthy that there is also a subcategory of individuals with chronic hyperventilation who show appropriate changes in CO 2 from rest to exercise or from rest to sleeping and possess exercise capacity similar to that of healthy participants. Therefore, Jack et al. (21) suggested that psychological variables such as anxiety-related factors should be assessed in this population, not only at rest but also in exercise-related situations. (21) More recently, Courtney et al. (17) argued that, when measurements of CO 2 at rest are not suggestive of DB, CO 2 should be measured during an exercise test, in a challenging situation (e.g., retrieving an old memory), or both. Similarly, Hagman et al. (1) identifi ed breathing diffi culties during exercise in patients with DB and in patients with asthma. In a subsequent study, the same group of authors found that a one-to three-month breathing retraining program ameliorated breathing diffi culties during exercise. (2) Notably, that improvement was maintained over a 5-year follow-up period. There is a need for systematic studies assessing exercise capacity, as well as physiological and psychological changes during exercise, in patients with primary DB. Given that HVS is a subcategory of DB and appears to have a negative effect during exercise, it is extremely relevant that the results of exercise capacity tests are taken into consideration when patients are suspected of having DB. Evaluation of individuals during exercise sessions or other stressful situations to diagnose DB could provide health care professionals with a broader, richer, and more nuanced perspective of the nature of the condition, as well as facilitating/expediting its diagnosis and treatment.
PSYCHOSOCIAL CHARACTERISTICS OF DB
Anxiety and depression
Although respiratory and cardiovascular parameters undergo signifi cant changes in emotionally challenging situations (i.e., the "fi ght-or-fl ight response" occurs) in all individuals, patients with DB commonly experience abnormal psychophysiological responses when facing similar scenarios. (9) DB induces signifi cant changes in the respiratory rate, breath-holding time, and depth of breathing that are primarily mediated by current or previous traumatic experiences or psychological conditions (e.g., anxiety). These symptoms may also occur chronically, which leads to deterioration of the QoL of the individual. (11, 63) Accordingly, a strong correlation between psychological condition and changes in normal breathing has been identifi ed in different contexts (e.g. during musical performances) in healthy individuals. (64) Anxiety and depression are common among patients with HVS. (10, 21, 47, 65) In fact, Hagman et al. (1) showed that the addition of DB to asthma (secondary DB) is associated with higher levels of anxiety and depression. However, the incidence of anxiety/depression in DB and whether such disorders are essential factors in the identifi cation of DB remain unclear and require further research.
QoL
Some authors have suggested that symptoms of DB secondary to asthma can infl uence HRQoL, as determined by the Asthma Quality of Life Questionnaire and the Medical Outcomes Study 36-item Short-Form Health Survey, two well-established tools for the assessment of HRQoL. (66, 67) Hagman et al. (1, 2) and Chenivesse et al. (59) assessed QoL in individuals with primary HVS and found that HRQoL was lower in those individuals than in groups of healthy participants. Hagman et al. (2) also proposed that breathing retraining had a positive effect on QoL even at the end of a 5-year follow-up period. However, a Cochrane systematic review investigating treatment for DB identifi ed only one randomized controlled trial (RCT) in this fi eld of research, and that trial did not include an assessment of QoL. (15) Given that DB may be associated with impaired QoL, it is crucial to gain greater insight and understanding of the impact that DB has on this parameter. Therefore, we believe that further research should be conducted in order to elucidate the psychophysiological and behavioral mechanisms that underlie DB. By identifying such triggers, clinicians are more likely to provide patients with an appropriate and effective treatment that will have various positive consequences on QoL.
TREATMENT OF DB
There are few data in the literature regarding treatment for patients with DB. That paucity can be explained by differences across studies in terms of the recruitment methods employed, which is understandable because that there is no standardized diagnostic tool available for DB. Therefore, it is extremely important to be cautious when considering these results in research or clinical practice.
In 2013, Jones et al. (15) published a systematic review looking at RCTs in which DB was treated with breathing exercises and the effects that those exercises had on patient QoL were evaluated. The authors identifi ed only one such RCT, conducted in the Netherlands, (68) in which 41 patients with HVS were evaluated. In that study, there were two intervention groups (relaxation therapy only and relaxation therapy plus breathing exercises) and a control group. The relaxation therapy was based on a combination of yoga techniques and the method devised by Jacobson. (69) The breathing exercises focused on reducing the respiratory rate and encouraging diaphragmatic breathing. Both intervention groups were treated in ten 60-min sessions. The study had two main outcome measures: the number and intensity of hyperventilation attacks; and the symptoms experienced. However, the authors did not specify how those parameters were assessed. The results show that there was a signifi cant reduction in number and intensity of hyperventilation attacks in both intervention groups in comparison with the control group, the patients in the relaxation therapy plus breathing exercises group improving more than did those in the relaxation therapy-only group.
Apart from the abovementioned RCT, the main therapeutic approach utilized for patients with DB is breathing retraining. (2, 6) In 2003, Thomas et al. (66) found that patients with DB secondary to asthma showed signifi cant symptom improvement after breathing retraining. In 2011, Hagman et al. (2) concluded that patients with DB benefi t from breathing retraining, even at the end of a 5-year follow-up period. In 2015, Jones et al. (6) found that manual therapy does not add benefi t to breathing retraining in the same population. However, the differences among recruitment methods, as well as among breathing retraining programs, and the lack of descriptions of protocols show the need for further clinical trials in this fi eld of research.
FINAL CONSIDERATIONS
Due to the multifaceted, complex nature of DB, a holistic multidimensional assessment is required for the accurate diagnosis of this respiratory condition. That being the case, three key domains-biochemical aspects, biomechanical aspects, and respiratory symptoms-require further investigation in order to improve our understanding of DB. (17, 25) In addition, based on our critical analysis of the existing literature, we believe that psychological, social, and physiological domains also have a signifi cant impact on the pathology and severity of DB (Figure 2 ). Finally, treatment for patients with DB needs to be better investigated, not only because of the lack of a diagnostic tool that would enable consistent recruitment of participants but also because of the scarcity of RCTs testing well-defi ned protocols for this patient group.
The lack of studies investigating the respiratory symptoms of DB, as well as its biochemical, biomechanical, psychological, social, and physiological aspects, perpetuates poor understanding and often results in delayed diagnosis of the condition. Therefore, the development of a multidimensional assessment tool specifi cally for DB, as well as a set of standardized clinical outcome measurements to identify and monitor treatment effi cacy, are essential prerequisites to improving the provision of effective health care services for individuals with DB. 
